azacitidine has been researched along with nitrophenols in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, T; Hosokawa, M | 1 |
| Andreeff, M; Antony, A; Coombes, KR; Kojima, K; Konoplev, S; Konopleva, M; Kornblau, S; Lu, H; Qiu, YH; Ruvolo, V; Shi, Y; Tsao, T; Zhang, N | 1 |
| Atadja, P; Banks, KM; Bergsagel, PL; Chesi, M; Doyle, MA; Ellul, J; Faulkner, D; Johnstone, RW; Lefebure, M; Matthews, GM; Shortt, J; Vidacs, E | 1 |
| Ahmann, G; Azorsa, DO; Bogenberger, JM; Braggio, E; Camoriano, J; Cardone, M; Choudhary, A; Chow, D; Coombes, KR; Fauble, V; Gonzales, IM; Kornblau, SM; Lena, R; Mantei, J; Mesa, RA; Pierceall, WE; Qiu, YH; Shi, CX; Stewart, AK; Tibes, R; Tiedemann, RE; Valdez, R; Yin, H | 1 |
| Bogenberger, JM; Delman, D; Fauble, V; Hansen, N; Mesa, RA; Tibes, R; Valdez, R | 1 |
| Wei, A | 1 |
6 other study(ies) available for azacitidine and nitrophenols
| Article | Year |
|---|---|
DNA methylation and its involvement in carboxylesterase 1A1 (CES1A1) gene expression.
Topics: Azacitidine; Base Sequence; Carboxylesterase; Cell Line; Decitabine; DNA Methylation; Gene Expression; Humans; Hydrolysis; Kidney; Liver; Molecular Sequence Data; Nitrophenols; RNA, Messenger; Transcriptional Activation | 2010 |
Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Biphenyl Compounds; Cell Line, Tumor; DNA Modification Methylases; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mitochondria; Neoplasm Proteins; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2012 |
Preclinical screening of histone deacetylase inhibitors combined with ABT-737, rhTRAIL/MD5-1 or 5-azacytidine using syngeneic Vk*MYC multiple myeloma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azacitidine; Biphenyl Compounds; Drug Screening Assays, Antitumor; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Mice; Mice, Inbred C57BL; Mice, Transgenic; Multiple Myeloma; Nitrophenols; Panobinostat; Piperazines; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Receptors, Death Domain; Recombinant Proteins; Sulfonamides; TNF-Related Apoptosis-Inducing Ligand | 2013 |
BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies.
Topics: Antimetabolites, Antineoplastic; Azacitidine; bcl-X Protein; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Myeloid Cell Leukemia Sequence 1 Protein; Myeloproliferative Disorders; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; RNA Interference; Sulfonamides | 2014 |
Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies.
Topics: Antineoplastic Agents; Azacitidine; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Humans; Leukemia, Myeloid; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Sulfonamides | 2015 |
ABT-199 partners with azacitidine to contest myeloid malignancies.
Topics: Antineoplastic Agents; Azacitidine; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Humans; Nitrophenols; Sulfonamides | 2015 |